TH1701002548A - Long-acting pharmaceutical constituents for hepatitis C - Google Patents

Long-acting pharmaceutical constituents for hepatitis C

Info

Publication number
TH1701002548A
TH1701002548A TH1701002548A TH1701002548A TH1701002548A TH 1701002548 A TH1701002548 A TH 1701002548A TH 1701002548 A TH1701002548 A TH 1701002548A TH 1701002548 A TH1701002548 A TH 1701002548A TH 1701002548 A TH1701002548 A TH 1701002548A
Authority
TH
Thailand
Prior art keywords
hepatitis
long
acting pharmaceutical
pharmaceutical constituents
constituents
Prior art date
Application number
TH1701002548A
Other languages
Thai (th)
Inventor
ฮอง
ฉี
ลีเวอร์ส
อาร์. มาร์ติน
Original Assignee
นายจักรพรรดิ์ มงคลสิทธิ์
นางสาวปรับโยชน์ ศรีกิจจาภรณ์
นายรุทร นพคุณ
Filing date
Publication date
Application filed by นายจักรพรรดิ์ มงคลสิทธิ์, นางสาวปรับโยชน์ ศรีกิจจาภรณ์, นายรุทร นพคุณ filed Critical นายจักรพรรดิ์ มงคลสิทธิ์
Publication of TH1701002548A publication Critical patent/TH1701002548A/en

Links

Claims (1)

: ข้อถือสิทธิ์ (ข้อที่หนึ่ง) ซึ่งจะปรากฏบนหน้าประกาศโฆษณา : แท็ก : สิทธิบัตรยา: Privilege (number one) that will appear on the advertisement page: Tag: drug patent
TH1701002548A 2015-10-30 Long-acting pharmaceutical constituents for hepatitis C TH1701002548A (en)

Publications (1)

Publication Number Publication Date
TH1701002548A true TH1701002548A (en) 2019-12-02

Family

ID=

Similar Documents

Publication Publication Date Title
TH1701002548A (en) Long-acting pharmaceutical constituents for hepatitis C
TH1701002546A (en) Composition, long-acting aggregates and methods for hepatitis C
TH1601004234A (en) Pharmaceutical constituents containing IgM
TH1701007724A (en)
TH1601005726A (en) New compound imidazobenzothiazole
TH180207A (en) Improved stability of glucagon derivatives (GLUCAGON DERIVATIVES).
TH1701001929A (en) Substitudate aminopureine compounds, their constituents, and their treatment methods
TH1601003539A (en) The conjugate of ANT-HER2 antibody-drug
TH1701003010A (en) Components for the treatment of schizophrenia
TH173755A (en) Pharmaceutical constituents containing lobeglutazone For oral dosing
TH1501003881A (en) Benzylamine derivatives
TH1601000693A (en) Early-release dosage form for JAK1 inhibitors.
TH181142A (en) Trk-inhibiting compounds
TH1601003963A (en) New glutamine inhibitors
TH1501005024A (en) Pharmaceutical constituents for the treatment of fungal infections.
TH1501005539A (en) Heteroeryl compounds and their uses
TH171939A (en) Aminopyrimidyl compounds Which are JAK inhibitors
TH1601002940A (en) Tetracyclic autotaxin inhibitors
TH1601003681A (en) Applications of isosazoline compounds in poultry
TH181825A (en) Diazacarbazole derivative as TAU-PET-Ligand
TH1601001924A (en) Heterocyclic compounds and their use
TH173918A (en) Triazole compounds
TH1501005347A (en) S-Ketamine Hydrochloride Pharmaceutical Composition
TH1601003237A (en)
TH1701003631A (en) Quinazoline derivatives used to treat HIV